HPV Update: Vaccination, Screening, and Associated Disease
Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even mo...
Gespeichert in:
| Veröffentlicht in: | Journal of general internal medicine : JGIM 2016-11, Vol.31 (11), p.1360-1366 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1366 |
|---|---|
| container_issue | 11 |
| container_start_page | 1360 |
| container_title | Journal of general internal medicine : JGIM |
| container_volume | 31 |
| creator | McNamara, Megan Batur, Pelin Walsh, Judith M. E. Johnson, Kay M. |
| description | Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even more extensive protection against several oncogenic HPV strains. Screening strategies for HPV are rapidly evolving, reflecting the essential role that HPV infection plays in cervical cancer. This article highlights new evidence regarding the efficacy of the recently approved 9-valent HPV (9vHPV) vaccine and the use of primary high-risk HPV testing in cervical cancer screening. We consider the utility of urinary HPV testing in routine clinical practice and review current guidelines regarding anal HPV screening. |
| doi_str_mv | 10.1007/s11606-016-3725-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5071275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2001386950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-b1048e06c5f0adc9e04b100e46fbe9622fc8cbae8eb319bcc2098d9ea3685f423</originalsourceid><addsrcrecordid>eNqNkV9LHDEUxUOx1HXtB-iLDPjSB6feZJJM4kNB_LcFoYVWX0Mmc2eN7GbWZFbQT2-WXW0rCD4l5P7uubnnEPKFwjcKUB8mSiXIEqgsq5qJ8vEDGVGRL5TreouMQCleqrri22QnpVsAWjGmPpFtVlPFa8FG5Gjy67q4WrR2wKPi2jrngx18Hw6K3y4iBh-mB4UNbXGcUu98xtri1Ce0CXfJx87OEn7enGNydX7252RSXv68-HFyfFk6AdVQNhS4QpBOdGBbpxF4fgLksmtQS8Y6p1xjUWFTUd04x0CrVqOtpBIdZ9WYfF_rLpbNHFuHYYh2ZhbRz218ML315v9K8Ddm2t8bATVltcgCXzcCsb9bYhrM3CeHs5kN2C-TyV5IDoJr_g6USamUVjKj-6_Q234ZQ3bCsJXTSuq8_5jQNeVin1LE7uXfFMwqRLMO0eQQzSpE85h79v5d-KXjObUMsDWQcilMMf4d_bbqE8aDpsg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2001386950</pqid></control><display><type>article</type><title>HPV Update: Vaccination, Screening, and Associated Disease</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>McNamara, Megan ; Batur, Pelin ; Walsh, Judith M. E. ; Johnson, Kay M.</creator><creatorcontrib>McNamara, Megan ; Batur, Pelin ; Walsh, Judith M. E. ; Johnson, Kay M.</creatorcontrib><description>Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even more extensive protection against several oncogenic HPV strains. Screening strategies for HPV are rapidly evolving, reflecting the essential role that HPV infection plays in cervical cancer. This article highlights new evidence regarding the efficacy of the recently approved 9-valent HPV (9vHPV) vaccine and the use of primary high-risk HPV testing in cervical cancer screening. We consider the utility of urinary HPV testing in routine clinical practice and review current guidelines regarding anal HPV screening.</description><identifier>ISSN: 0884-8734</identifier><identifier>EISSN: 1525-1497</identifier><identifier>DOI: 10.1007/s11606-016-3725-z</identifier><identifier>PMID: 27184752</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anal cancer ; Cancer ; Cancer screening ; Cervical cancer ; Cervix ; Early Detection of Cancer - methods ; Female ; Genital cancers ; Health risks ; Human papillomavirus ; Humans ; Immunization ; Infections ; Internal Medicine ; Medical screening ; Medicine ; Medicine & Public Health ; Papillomaviridae ; Papillomaviridae - drug effects ; Papillomaviridae - isolation & purification ; Papillomavirus Infections - diagnosis ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - therapeutic use ; Review Paper ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - prevention & control ; Vaccination ; Vaccination - methods ; Vaccines ; Vagina</subject><ispartof>Journal of general internal medicine : JGIM, 2016-11, Vol.31 (11), p.1360-1366</ispartof><rights>Society of General Internal Medicine 2016</rights><rights>Journal of General Internal Medicine is a copyright of Springer, (2016). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-b1048e06c5f0adc9e04b100e46fbe9622fc8cbae8eb319bcc2098d9ea3685f423</citedby><cites>FETCH-LOGICAL-c503t-b1048e06c5f0adc9e04b100e46fbe9622fc8cbae8eb319bcc2098d9ea3685f423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071275/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071275/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27184752$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNamara, Megan</creatorcontrib><creatorcontrib>Batur, Pelin</creatorcontrib><creatorcontrib>Walsh, Judith M. E.</creatorcontrib><creatorcontrib>Johnson, Kay M.</creatorcontrib><title>HPV Update: Vaccination, Screening, and Associated Disease</title><title>Journal of general internal medicine : JGIM</title><addtitle>J GEN INTERN MED</addtitle><addtitle>J Gen Intern Med</addtitle><description>Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even more extensive protection against several oncogenic HPV strains. Screening strategies for HPV are rapidly evolving, reflecting the essential role that HPV infection plays in cervical cancer. This article highlights new evidence regarding the efficacy of the recently approved 9-valent HPV (9vHPV) vaccine and the use of primary high-risk HPV testing in cervical cancer screening. We consider the utility of urinary HPV testing in routine clinical practice and review current guidelines regarding anal HPV screening.</description><subject>Anal cancer</subject><subject>Cancer</subject><subject>Cancer screening</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Genital cancers</subject><subject>Health risks</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infections</subject><subject>Internal Medicine</subject><subject>Medical screening</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Papillomaviridae</subject><subject>Papillomaviridae - drug effects</subject><subject>Papillomaviridae - isolation & purification</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Vaccines - therapeutic use</subject><subject>Review Paper</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - prevention & control</subject><subject>Vaccination</subject><subject>Vaccination - methods</subject><subject>Vaccines</subject><subject>Vagina</subject><issn>0884-8734</issn><issn>1525-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkV9LHDEUxUOx1HXtB-iLDPjSB6feZJJM4kNB_LcFoYVWX0Mmc2eN7GbWZFbQT2-WXW0rCD4l5P7uubnnEPKFwjcKUB8mSiXIEqgsq5qJ8vEDGVGRL5TreouMQCleqrri22QnpVsAWjGmPpFtVlPFa8FG5Gjy67q4WrR2wKPi2jrngx18Hw6K3y4iBh-mB4UNbXGcUu98xtri1Ce0CXfJx87OEn7enGNydX7252RSXv68-HFyfFk6AdVQNhS4QpBOdGBbpxF4fgLksmtQS8Y6p1xjUWFTUd04x0CrVqOtpBIdZ9WYfF_rLpbNHFuHYYh2ZhbRz218ML315v9K8Ddm2t8bATVltcgCXzcCsb9bYhrM3CeHs5kN2C-TyV5IDoJr_g6USamUVjKj-6_Q234ZQ3bCsJXTSuq8_5jQNeVin1LE7uXfFMwqRLMO0eQQzSpE85h79v5d-KXjObUMsDWQcilMMf4d_bbqE8aDpsg</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>McNamara, Megan</creator><creator>Batur, Pelin</creator><creator>Walsh, Judith M. E.</creator><creator>Johnson, Kay M.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161101</creationdate><title>HPV Update: Vaccination, Screening, and Associated Disease</title><author>McNamara, Megan ; Batur, Pelin ; Walsh, Judith M. E. ; Johnson, Kay M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-b1048e06c5f0adc9e04b100e46fbe9622fc8cbae8eb319bcc2098d9ea3685f423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anal cancer</topic><topic>Cancer</topic><topic>Cancer screening</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Genital cancers</topic><topic>Health risks</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infections</topic><topic>Internal Medicine</topic><topic>Medical screening</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Papillomaviridae</topic><topic>Papillomaviridae - drug effects</topic><topic>Papillomaviridae - isolation & purification</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Vaccines - therapeutic use</topic><topic>Review Paper</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - prevention & control</topic><topic>Vaccination</topic><topic>Vaccination - methods</topic><topic>Vaccines</topic><topic>Vagina</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McNamara, Megan</creatorcontrib><creatorcontrib>Batur, Pelin</creatorcontrib><creatorcontrib>Walsh, Judith M. E.</creatorcontrib><creatorcontrib>Johnson, Kay M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of general internal medicine : JGIM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNamara, Megan</au><au>Batur, Pelin</au><au>Walsh, Judith M. E.</au><au>Johnson, Kay M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HPV Update: Vaccination, Screening, and Associated Disease</atitle><jtitle>Journal of general internal medicine : JGIM</jtitle><stitle>J GEN INTERN MED</stitle><addtitle>J Gen Intern Med</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>31</volume><issue>11</issue><spage>1360</spage><epage>1366</epage><pages>1360-1366</pages><issn>0884-8734</issn><eissn>1525-1497</eissn><abstract>Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even more extensive protection against several oncogenic HPV strains. Screening strategies for HPV are rapidly evolving, reflecting the essential role that HPV infection plays in cervical cancer. This article highlights new evidence regarding the efficacy of the recently approved 9-valent HPV (9vHPV) vaccine and the use of primary high-risk HPV testing in cervical cancer screening. We consider the utility of urinary HPV testing in routine clinical practice and review current guidelines regarding anal HPV screening.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>27184752</pmid><doi>10.1007/s11606-016-3725-z</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0884-8734 |
| ispartof | Journal of general internal medicine : JGIM, 2016-11, Vol.31 (11), p.1360-1366 |
| issn | 0884-8734 1525-1497 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5071275 |
| source | MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Anal cancer Cancer Cancer screening Cervical cancer Cervix Early Detection of Cancer - methods Female Genital cancers Health risks Human papillomavirus Humans Immunization Infections Internal Medicine Medical screening Medicine Medicine & Public Health Papillomaviridae Papillomaviridae - drug effects Papillomaviridae - isolation & purification Papillomavirus Infections - diagnosis Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Vaccines - therapeutic use Review Paper Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Vaccination Vaccination - methods Vaccines Vagina |
| title | HPV Update: Vaccination, Screening, and Associated Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T20%3A49%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HPV%20Update:%20Vaccination,%20Screening,%20and%20Associated%20Disease&rft.jtitle=Journal%20of%20general%20internal%20medicine%20:%20JGIM&rft.au=McNamara,%20Megan&rft.date=2016-11-01&rft.volume=31&rft.issue=11&rft.spage=1360&rft.epage=1366&rft.pages=1360-1366&rft.issn=0884-8734&rft.eissn=1525-1497&rft_id=info:doi/10.1007/s11606-016-3725-z&rft_dat=%3Cproquest_pubme%3E2001386950%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2001386950&rft_id=info:pmid/27184752&rfr_iscdi=true |